INDV insiders were on both sides of the trade this year. Buys came to roughly $312,000 (seven buyers), sales to $2.8 million (two sellers).
Biggest single buyer: Wheadon David E., Director, with roughly $63,000.
Quarter by quarter: 2 quarters in a row of net selling by insiders. Insiders bought in 2 of the last 7 full quarters. On the institutional side, 338 funds reported holding INDV at the end of Q2 2026, and more funds bought than sold.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Aug 27, 2026 | Anderson Woodrow D | Executive Officer | Buy | 1,500 | $35.69 | $54K | SEC |
| Aug 5, 2026 | Anderson Woodrow D | Executive Officer | Buy | 1,500 | $36.28 | $54K | SEC |
| Jul 13, 2026 | Heidbreder Christian | Executive Officer | Sell | 18,586 | $41.14 | $765K | SEC |
| Jun 12, 2026 | Heidbreder Christian | Executive Officer | Sell | 18,586 | $38.06 | $707K | SEC |
| Jun 10, 2026 | Preblick Ryan | CFO | Sell | 36,000 | $37.70 | $1.4M | SEC |
| Mar 13, 2026 | Ryan Barbara | Director | Buy | 8 | $31.09 | $249 | SEC |
| Mar 11, 2026 | Kingsley Stuart A | Director | Buy | 940 | $31.87 | $30K | SEC |
| Mar 11, 2026 | Ryan Barbara | Director | Buy | 31 | $32.56 | $1K | SEC |
| Jan 7, 2026 | Ryan Barbara | Director | Buy | 775 | $35.39 | $27K | SEC |
| Jan 7, 2026 | Humphreys Keith | Director | Buy | 775 | $35.39 | $27K | SEC |
| Jan 7, 2026 | NINIVAGGI DANIEL A | Director | Buy | 775 | $35.39 | $27K | SEC |
| Jan 7, 2026 | Stejbach Mark | Director | Buy | 775 | $35.39 | $27K | SEC |
| Jan 7, 2026 | Wheadon David E. | Director | Buy | 1,771 | $35.39 | $63K | SEC |
In the last 12 months Indivior Pharmaceuticals, Inc. insiders made open-market purchases worth about $312,000 and sales worth about $2.8 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in INDV was filed on 2026-08-27.
338 investment managers reported holding INDV in SEC Form 13F filings for Q2 2026.
No congressional trades in INDV were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).